-- 
Air Berlin, Commerzbank, Deutsche Bank: German Equity Preview

-- B y   A n d r e a s   C r e m e r   a n d   J u l i e   C r u z
-- 
2011-09-06T06:28:55Z

-- http://www.bloomberg.com/news/2011-09-05/allianz-commerzbank-evotec-gagfah-german-equity-preview.html
The following is a list of companies
whose shares may have unusual price changes in  Germany . Stock
symbols are in parentheses, and share prices are from the
previous close.  DAX Index (DAX)  futures expiring in September lost 0.3 percent to
5,241.50 as of 8:20 a.m. in Frankfurt. The benchmark DAX Index
slumped 5.3 percent to 5,246.18 yesterday.  Air Berlin Plc (AB1 GY): The airline’s August passenger
numbers rose just under 1 percent to nearly 3.76 million as its
 load factor  increased 1.7 percentage points to 85.1 percent
compared with the year-ago period. Seat capacity fell 1.1
percent, the company said in an e-mailed statement today. The
shares declined 5.4 percent to 2.65 euros.  Allianz SE (ALV)  :  Europe ’s biggest insurer may focus on
 Brazil  for further growth at its industrial unit, Boersen-
Zeitung reported, citing division chief Axel Theis. The shares
dropped 6.1 percent to 63.85 euros.  Commerzbank AG (CBK)  : Martin Blessing, chief executive
officer of Germany’s second-largest lender, said he doesn’t
expect Commerzbank to become a takeover target, Handelsblatt
reported. The stock declined 5.9 percent to 1.81 euros.  Deutsche Bank AG (DBK)  : Germany’s biggest bank was
raised to “overweight” from “neutral” at JPMorgan Chase &
Co. The shares plummeted 8.9 percent to 23.72 euros.  Deutz AG (DEZ GY),  Kuka AG (KU2)  (KU2 GY), GSW Immobilien AG (GIB
GY): Deutsche Boerse AG said the three companies will join the
MDAX Index for medium-sized companies, replacing Praktiker AG,
Demag Cranes AG and IVG Immobilien AG. Deutz slid 4.2 percent to
4.36 euros, while Kuka retreated 5.5 percent to 13.54 euros. GSW
Immobilien slipped 1.4 percent to 21.99 euros.  Evotec AG (EVT)  :  Roche Holding AG  will pay the drug-
development company $10 million for the right to develop
Evotec’s EVT 302 compound for  Alzheimer’s disease . Evotec may
receive as much as another $820 million if development and sales
goals are met. The shares fell 5.6 percent to 1.84 euros.  Gagfah SA (GFJ)  : Germany’s largest publicly traded
property company made a 75 million-euro offer to shareholders to
buy back their shares. The offer will be made through a modified
Dutch auction tender with an offer price range between 3.50
euros and 5 euros per share, the company said. The stock fell
1.7 percent to 3.85 euros.  Lanxess AG (LXS)  : The chemicals maker spun off from
Bayer AG in 2005 was raised to “neutral” from “sell” at UBS
AG. The shares sank 7.1 percent to 36.49 euros.  To contact the reporters on this story:
Andreas Cremer in Berlin at 
 acremer@bloomberg.net ;
Julie Cruz in  Frankfurt  at 
 jcruz6@bloomberg.net   To contact the editors responsible for this story:
Chad Thomas at 
 cthomas16@bloomberg.net 
Andrew Rummer at   arummer@bloomberg.net  